124 related articles for article (PubMed ID: 9589055)
1. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
3. Change in telomerase activity during human colorectal carcinogenesis.
Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
[TBL] [Abstract][Full Text] [Related]
4. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Tahara H; Kuniyasu H; Yokozaki H; Yasui W; Shay JW; Ide T; Tahara E
Clin Cancer Res; 1995 Nov; 1(11):1245-51. PubMed ID: 9815918
[TBL] [Abstract][Full Text] [Related]
7. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
9. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
10. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in different clinical staging of colorectal adenocarcinoma.
Lukman K; Maskoen AM; Achmad TH; Hanafi B; Karnadihardja W
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():491-7. PubMed ID: 10895200
[TBL] [Abstract][Full Text] [Related]
12. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.
Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
J Pathol; 2001 Jan; 193(1):21-6. PubMed ID: 11169511
[TBL] [Abstract][Full Text] [Related]
13. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features.
Simsek BC; Pehlivan S; Karaoglu A
Ann Diagn Pathol; 2010 Dec; 14(6):413-7. PubMed ID: 21074689
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activation in colorectal carcinogenesis.
Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
J Pathol; 1999 Oct; 189(2):207-12. PubMed ID: 10547576
[TBL] [Abstract][Full Text] [Related]
16. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
19. [Telomerase activity in stool of patients with colorectal cancer].
Luo C; Zhao D; Qu J
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):580-2. PubMed ID: 11758190
[TBL] [Abstract][Full Text] [Related]
20. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]